Cargando…

Danger ahead: COVID-19 infections after vaccination

Detalles Bibliográficos
Autores principales:	Greenberger, Lee M., Nichols, Gwen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Blood Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908798/ https://www.ncbi.nlm.nih.gov/pubmed/35267005 http://dx.doi.org/10.1182/blood.2021014505

Ejemplares similares

Vaccination against COVID-19: a challenge in CLL
por: Eichhorst, Barbara
Publicado: (2021)

Buckling up against COVID-19 after CAR T-cell therapy
por: Auletta, Jeffery J.
Publicado: (2022)

Another front in COVID-19’s perfect storm
por: Jobe, Shawn M., et al.
Publicado: (2021)

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

Thrombosis with COVID-19: kids get it too
por: Takemoto, Cliff
Publicado: (2021)

Vaccinations and ITP: keep on track(ing)
por: Bakchoul, Tamam, et al.
Publicado: (2022)

VITT(al) insights into vaccine-related clots
por: Strich, Jeffrey R., et al.
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
por: Liebers, Nora, et al.
Publicado: (2022)

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022)

COVID-19 vaccination and critical care capacity: Perilous months ahead
por: Reperant, Leslie A., et al.
Publicado: (2021)

House calls for stem cell transplant patients during the COVID-19 pandemic
por: Sung, Anthony D., et al.
Publicado: (2020)

COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
por: Gerber, Gloria F., et al.
Publicado: (2021)

Hypersegmented granulocytes and COVID-19 infection
por: Salib, Christian, et al.
Publicado: (2020)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
por: Picod, Adrien, et al.
Publicado: (2022)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
por: Pagano, Livio, et al.
Publicado: (2022)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Why B(-)other? About the gap of unknowns in ALL
por: Fioretos, Thoas
Publicado: (2022)

Tet2 helps blood cells balance in air
por: Chute, John P.
Publicado: (2022)

Platelets get particular
por: Rauova, Lubica, et al.
Publicado: (2022)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

The race to stymie BTK: zanu zings
por: Kapoor, Prashant, et al.
Publicado: (2020)

Understanding VITT(ual) reality
por: Rauova, Lubica, et al.
Publicado: (2021)

Neutrophils clear sterile inflammatory debris
por: Yost, Christian Con
Publicado: (2021)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
por: Blixt, Lisa, et al.
Publicado: (2022)

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
por: Ghione, Paola, et al.
Publicado: (2021)

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022)

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders
por: La, Jennifer, et al.
Publicado: (2022)

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
por: Treon, Steven P., et al.
Publicado: (2020)

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
por: Tremblay, Douglas, et al.
Publicado: (2020)

Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose
por: Krzywicka, Katarzyna, et al.
Publicado: (2022)

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
por: Xia, Xinyi, et al.
Publicado: (2020)

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia
por: Bellusci, Lorenza, et al.
Publicado: (2022)

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
por: Dhakal, Binod, et al.
Publicado: (2021)

Anticoagulation in hospitalized patients with COVID-19
por: Baumann Kreuziger, Lisa, et al.
Publicado: (2022)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6u5de1tl4oms4am3nfgvlf3t30